Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Mar 18;17:1721–1733. doi: 10.2147/JIR.S451538

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2024 Wang et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Nomogram for estimating the probability of vasculopathy progression in MMD patients and its predictive performance. (A and B) Representative DSA of vasculopathy progression. An adult patient with progressive bilateral vasculopathy. The average Suzuki stage upgraded from III (A) to V (B), with the decrease of complement C3 from 110 mg/dL to 75.4 mg/dL at the follow-up. (C) A nomogram to predict probability of vasculopathy progression in MMD was established. (D and E) Calibration plot and decision curve analysis (DCA) were used to assess the nomogram model and other models. The nomogram model presented with good accuracy and clinical benefits.